Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis

The Syndrome of Combined Pulmonary Fibrosis and Emphysema

From Anti-inflammatory Drugs Through Antifibrotic Agents to Lung Transplantation: A Long Road of Research, Clinical Attempts, and Failures in the Treatment of Idiopathic Pulmonary Fibrosis

Preoperative Evaluation of Patients With Interstitial Lung Disease

Fibroblastic Foci: Time To Be Counted?

The respiratory microbiome after lung transplantation: Reflection or driver of respiratory disease?

Air Travel and Pneumothorax

A Role for the Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis

The polymorphism C5507G of complement receptor 1 does not explain idiopathic pulmonary fibrosis among the Finns

Asthma and Gastroesophageal Reflux: Another Piece in the Puzzle?

Therapeutic Targeting of CC Ligand 21 or CC Chemokine Receptor 7 Abrogates Pulmonary Fibrosis Induced by the Adoptive Transfer of Human Pulmonary Fibroblasts to Immunodeficient Mice

Uncovering the Risk of Inhalational Exposures Across Interstitial Lung Diseases

Pulmonary Hypertension: From an Orphan Disease to a Public Health Problem

The Spectrum of Smoking-Related Interstitial Lung Disorders: The Never-Ending Story of Smoke and Disease

Insulin-Like Growth Factor-II Is Increased in Systemic Sclerosis-Associated Pulmonary Fibrosis and Contributes to the Fibrotic Process via Jun N-Terminal Kinase- and Phosphatidylinositol-3 Kinase-Dependent Pathways

Environmental factors